A St. Jude Children’s Research Hospital–led collaboration created the first large-scale neurodegenerative disease proteome map, a resource for developing new diagnosis tools and treatments.

A Finnish clinical imaging study shows that rest tremor in Parkinson’s disease is not explained by greater dopamine loss. In contrast, tremor appears to be associated with relatively better-preserved dopamine function.

A drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method, a study shows.

The International Society for Stem Cell Research (ISSCR) today announced the launch of Stem Cell Medicine: Parkinson’s Disease, a new continuing education course designed to equip clinicians with an evidence-based understanding of emerging stem cell therapies for Parkinson’s disease (PD).

Building on the success of the Society’s inaugural course, Stem Cell Medicine: From Scientific Research to Patient Care, this disease-focused program provides physicians and other healthcare professionals with deeper insight into how advances in stem cell science are moving toward clinical application in one of the most intensively studied neurological disorders.

Salk researchers create epigenetic atlas of cell type-specific changes in the aging mouse brain, representing eight different brain regions and 36 different cell types to show clear epigenetic differences associated with different ages. The new resource—available publicly on Amazon Web services—can be used to unravel age-related contributions to neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS.